CHANDIGARH: To identify new variants of coronavirus, Punjab Government has commenced its first state-run COVID-19 genome sequencing facility at VRDL GMC Patiala laboratory. About 150 samples have been tested in lab, so far and no new variant of coronavirus is identified.
Giving details in a press statement, the Health Minister said that earlier, the State Government has sent all samples of suspected patients of new variants at NCDS Delhi where they took more than a month to provide confirmation of new variants. As per the experts, if any case of new variant found in a specific area then there is immediate need to conduct contact tracing and testing of all suspected patients to further prevent the spread of virus. He said that with the availability of genome sequencing facility at GMC Patiala, the reports are now getting in 5 to 6 days.
Underlining the features of the facility, the Health Minister said that the laboratory received the MinION Mk1C developed by UK based manufacturer- Oxford Nanopore. MinION is a unique compact and portable USB-powered device that allows one to sequence both DNA and RNA with real-time analysis providing immediate access to actionable results. The genome sequencer and supportive equipment has been donated by a US based non-profit organisation, PATH as part of their on-going COVID-19 response support to the state.
Louding efforts being made by the in-charge at VRDL GMC Patiala, Mr. Sidhu said that Dr Rupinder Bakshi and her staff have been tirelessly serving the state since the beginning of the pandemic in March last year. The lab has been recognized among the top 5 labs in COVID-19 RT-PCR testing capacity by ICMR across India. To build on the lab's existing capacity, a team of research assistants and microbiologists, including the in-charge, Dr Bakshi, have been trained in conducting COVID-19 genome sequencing by a team of experts from Genotypics, a Bangalore-based sequencing research hub. The state has initiated conversations to become a part of the central sequencing consortium, INSACOG.